Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Paraplegic engineer becomes the first wheelchair user to blast into space - 2Shelby County deputies charged with assault, placed on leave
- 3Instructions to Perceive and Grasp the Early Side effects of Cellular breakdown in the lungs
- 4Step by step instructions to Choose the Right Internet based Degree Program for Your Future
- 5Photos: Hundreds Gather at Bondi Beach After Deadly Attack
- 2 new malaria treatments announced as drug resistance grows
- Chicago reports first rabies-positive dog in 61 years. What we know.
- Manual for Big name Work out schedules
- Turkey's Erdogan denounces Israel-Greece-Cyprus trilateral summit, affirms support for Gaza
- Germany unveils rescue plan for struggling chemical sector
- Sixteen Kenyans missing in Russia after army recruitment
- After fleeing past Hezbollah fighting, some Israelis on northern border vow to stay
- Blue Origin's next space tourism flight will break new ground for people with disabilities
- Why the weirdest sea level changes on Earth are happening off the coast of Japan
